245 related articles for article (PubMed ID: 27709279)
1. Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson's disease: A diagnostic performance study and meta-analysis.
Hirata FCC; Sato JR; Vieira G; Lucato LT; Leite CC; Bor-Seng-Shu E; Pastorello BF; Otaduy MCG; Chaim KT; Campanholo KR; Novaes NP; Melo LM; Gonçalves MR; do Nascimento FBP; Teixeira MJ; Barbosa ER; Amaro E; Cardoso EF
Eur Radiol; 2017 Jun; 27(6):2640-2648. PubMed ID: 27709279
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
[TBL] [Abstract][Full Text] [Related]
4. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.
Schwarz ST; Abaei M; Gontu V; Morgan PS; Bajaj N; Auer DP
Neuroimage Clin; 2013; 3():481-8. PubMed ID: 24273730
[TBL] [Abstract][Full Text] [Related]
5. High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.
Knossalla F; Kohl Z; Winkler J; Schwab S; Schenk T; Engelhorn T; Doerfler A; Gölitz P
J Clin Neurosci; 2018 Apr; 50():199-202. PubMed ID: 29366621
[TBL] [Abstract][Full Text] [Related]
6. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.
Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Azevedo P; Ferreira J; Abreu D; Gonçalves N; Nunes RG; Campos J; Ferreira JJ
Mov Disord; 2015 Jun; 30(7):953-9. PubMed ID: 25758364
[TBL] [Abstract][Full Text] [Related]
7. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.
Prakash BD; Sitoh YY; Tan LC; Au WL
Parkinsonism Relat Disord; 2012 Nov; 18(9):1029-33. PubMed ID: 22705126
[TBL] [Abstract][Full Text] [Related]
8. [Parkinson's disease: diffusion kurtosis imaging and the correlation with clinical manifestations].
Sun YQ; Zhang Q; Jiang Z; Zhang CY; Zhang JW; Chen H; Shen JK
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3534-3537. PubMed ID: 29275590
[No Abstract] [Full Text] [Related]
9. Fractional anisotropy in the substantia nigra in Parkinson's disease: a complex picture.
Lenfeldt N; Larsson A; Nyberg L; Birgander R; Forsgren L
Eur J Neurol; 2015 Oct; 22(10):1408-14. PubMed ID: 26118635
[TBL] [Abstract][Full Text] [Related]
10. Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease.
Aquino D; Contarino V; Albanese A; Minati L; Farina L; Grisoli M; Romita L; Elia AE; Bruzzone MG; Chiapparini L
Neurol Sci; 2014 May; 35(5):753-8. PubMed ID: 24337946
[TBL] [Abstract][Full Text] [Related]
11. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
Arribarat G; Pasternak O; De Barros A; Galitzky M; Rascol O; Péran P
Parkinsonism Relat Disord; 2019 Aug; 65():146-152. PubMed ID: 31182373
[TBL] [Abstract][Full Text] [Related]
12. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
[TBL] [Abstract][Full Text] [Related]
14. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
[TBL] [Abstract][Full Text] [Related]
15. Diffusion basis spectrum imaging detects pathological alterations in substantia nigra and white matter tracts with early-stage Parkinson's disease.
Hu Z; Sun P; George A; Zeng X; Li M; Lin TH; Ye Z; Wei X; Jiang X; Song SK; Yang R
Eur Radiol; 2023 Dec; 33(12):9109-9119. PubMed ID: 37438642
[TBL] [Abstract][Full Text] [Related]
16. Neuromelanin-Sensitive Magnetic Resonance Imaging as a Measure for Differential Diagnosis of Essential Tremor and Parkinson's Disease.
Xuan T; Fang X; Xu T; Ma T; Zhang J; Wang Z; Li H
Neurol India; 2023; 71(4):716-724. PubMed ID: 37635504
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
[TBL] [Abstract][Full Text] [Related]
18. Microstructural changes in the substantia nigra of asymptomatic agricultural workers.
Du G; Lewis MM; Sterling NW; Kong L; Chen H; Mailman RB; Huang X
Neurotoxicol Teratol; 2014; 41():60-4. PubMed ID: 24334261
[TBL] [Abstract][Full Text] [Related]
19. MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra.
Skorpil M; Söderlund V; Sundin A; Svenningsson P
J Parkinsons Dis; 2012; 2(2):171-80. PubMed ID: 23939442
[TBL] [Abstract][Full Text] [Related]
20. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.
Vaillancourt DE; Spraker MB; Prodoehl J; Abraham I; Corcos DM; Zhou XJ; Comella CL; Little DM
Neurology; 2009 Apr; 72(16):1378-84. PubMed ID: 19129507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
